Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, April 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 94 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 37 publications that cite this research output.

37

The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.

The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

Article in Diabetes Obesity and Metabolism (January 2024)

Prusogliptin (DBPR108) monotherapy in treatment‐naïve patients with type 2 diabetes: A randomized, double‐blind, active and placebo‐controlled, phase 3 study

Article in Diabetes Obesity and Metabolism (January 2024)

Novel Approaches in Chronic Renal Failure without Renal Replacement Therapy: A Review

Article in Biomedicines (October 2023)